Haemonetics HAE Blood Center — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's blood center — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's blood center — operating income?
- Haemonetics (HAE) reported blood center — operating income of $11.24M in Q1 2026.
- How has Haemonetics's blood center — operating income changed year-over-year?
- Haemonetics's blood center — operating income increased by 13.3% year-over-year, from $9.92M to $11.24M.
- What is the long-term trend for Haemonetics's blood center — operating income?
- Over 2 years (2022 to 2026), Haemonetics's blood center — operating income has grown at a -39.5% compound annual growth rate (CAGR), from $136.69M to $49.98M.
- What does blood center — operating income mean?
- Measures the profitability of the Blood Center segment after accounting for both cost of goods sold and operating expenses. It indicates the core operational performance and the ability of the segment to generate earnings from its primary business activities. This is a key indicator of the segment's overall financial health and contribution to the company's bottom line.